But first-line medication—including ropinirole (Requip) and pramipexole (Mirapex), which the Food and Drug Administration approved for the treatment of RLS—are sometimes unsuccessful because ...

Background Ropinirole prolonged release (RPR) is a once-daily formulation. However, there may be individual pharmacokinetic differences so that multiple dosing may be preferred in some individuals.

MoA Aggressive Allocation Fund earns a High Process Pillar rating. The leading factor in the rating is its parent firm's excellent long-term risk-adjusted performance, as shown by the firm's ...

MoA International Fund earns a High Process Pillar rating. The largest contributor to the rating is its parent firm's impressive long-term risk-adjusted performance, as shown by the firm's average ...

Company law mandates that either a private or public company create a Memorandum of Association (MOA) upon incorporation. When the company is first founded, the petition needs to be filed to the ...